Overview
For patients with lung cancer who require radiation therapy — whether as a curative alternative to surgery, as part of a combined modality treatment for locally advanced disease, or for oligometastatic disease control — the precision and expertise of the radiation oncology team are critical determinants of outcome. Shanghai Pulmonary Hospital, one of China's premier dedicated thoracic disease centers, offers world-class stereotactic body radiotherapy (SBRT) and intensity-modulated radiation therapy (IMRT) for lung cancer and other thoracic tumors.
China Medical Concierge Shanghai (CMCS) connects international patients with Shanghai's top thoracic radiation oncologists, providing end-to-end support from remote consultation through to post-treatment follow-up.
Understanding Lung Cancer & Radiation Therapy
When Is Radiation Therapy Used in Lung Cancer?
Radiation therapy is used across the full spectrum of lung cancer management:
- Early-stage NSCLC (Stage I-II) — SBRT for patients who cannot undergo surgery; achieves local control rates of 90–95% at 3 years, comparable to surgical resection
- Locally advanced NSCLC (Stage III) — concurrent chemoradiotherapy (IMRT + platinum-based chemotherapy) followed by durvalumab consolidation (PACIFIC regimen)
- Oligometastatic disease — SBRT for limited metastatic lesions in the lung, liver, adrenal glands, or bone
- Brain metastases — stereotactic radiosurgery (SRS) for limited brain involvement
- Small cell lung cancer (SCLC) — thoracic radiotherapy combined with chemotherapy for limited-stage disease
- Palliative radiotherapy — symptom control for advanced disease (pain, haemoptysis, airway obstruction)
Common Symptoms of Lung Cancer
- Persistent cough or haemoptysis
- Chest pain or shortness of breath
- Hoarseness and unexplained weight loss
- Recurrent respiratory infections
- Bone pain or neurological symptoms (metastatic disease)
Precision Radiation Techniques
Stereotactic Body Radiotherapy (SBRT)
SBRT is the most advanced form of external beam radiotherapy for lung cancer, delivering very high doses of precisely targeted radiation in a small number of fractions (typically 3–5 treatments). Key advantages include:
- Local control rates of 90–95% for early-stage NSCLC — comparable to surgical resection
- Non-invasive — no surgery, no general anaesthesia, no hospital admission required
- Minimal side effects — precise targeting minimizes radiation to healthy lung tissue
- Short treatment course — typically completed in 1–2 weeks
- Suitable for patients with poor lung function or cardiac disease who cannot tolerate surgery
SBRT is also highly effective for oligometastatic disease — delivering ablative doses to limited metastatic lesions to achieve durable local control and potentially improve overall survival when combined with systemic therapy.
Intensity-Modulated Radiation Therapy (IMRT)
IMRT is the standard technique for locally advanced lung cancer treatment, using computer-optimized radiation beams to precisely shape the dose distribution around the tumor while minimizing exposure to the lungs, heart, spinal cord, and esophagus. IMRT enables higher tumor doses with lower toxicity compared to conventional radiotherapy, improving both efficacy and tolerability.
Motion Management for Lung Tumors
Because the lung moves with breathing, precise motion management is essential for accurate radiation delivery. Advanced techniques including respiratory gating, breath-hold, and real-time tumor tracking ensure that radiation is delivered precisely to the tumor throughout the breathing cycle, minimizing geographic miss and reducing unnecessary normal tissue irradiation.
Why Choose Shanghai Pulmonary Hospital for Lung Cancer Radiotherapy?
- China's premier dedicated pulmonary disease center — one of China's largest and most specialized hospitals for lung and thoracic conditions
- Advanced SBRT and IMRT technology — state-of-the-art radiation delivery systems with motion management capabilities
- High-volume thoracic oncology experience — one of China's highest-volume lung cancer centers across all treatment modalities
- Rapid diagnostic pathway — the hospital's pioneering 4-day diagnostic pathway ensures that radiation treatment planning can begin without delay
- Cost-effective world-class care — significantly lower cost than equivalent treatment in the US, UK, or Singapore
Featured Specialist: Dr. Li Fangjuan — Shanghai Pulmonary Hospital
Dr. Li Fangjuan (李芳娟) is an Associate Chief Physician of Radiation Oncology at Shanghai Pulmonary Hospital — one of China's premier dedicated thoracic disease centers. She specializes in stereotactic body radiotherapy (SBRT) and intensity-modulated radiation therapy (IMRT) for lung cancer and other thoracic tumors.
SBRT Expertise
Dr. Li's primary clinical focus is SBRT for thoracic malignancies — delivering high-dose, precisely targeted radiation for early-stage lung cancer, oligometastatic disease, and other thoracic tumors where ablative radiotherapy offers the best chance of durable local control. Her expertise in SBRT planning and delivery, including advanced motion management techniques, ensures that each patient receives the most precise and effective treatment possible.
IMRT for Locally Advanced Disease
For patients with locally advanced lung cancer requiring concurrent chemoradiotherapy, Dr. Li's expertise in IMRT enables high-dose treatment with optimal sparing of critical structures — maximizing tumor control while minimizing the risk of radiation pneumonitis, cardiac toxicity, and esophagitis.
Clinical Expertise
- SBRT for early-stage and oligometastatic lung cancer — high-dose ablative radiotherapy for inoperable early-stage NSCLC and limited metastatic disease
- IMRT for locally advanced lung cancer — concurrent chemoradiotherapy for stage III NSCLC
- Motion management — respiratory gating, breath-hold, and real-time tracking for precise lung tumor targeting
- Other thoracic tumors — thymoma, mesothelioma, and other thoracic malignancies
- Individualized radiotherapy planning — treatment precisely tailored to each patient's tumor anatomy and clinical situation
For international patients, Dr. Li's team offers remote pre-consultation review of CT scans, PET-CT, and pathology, enabling a precise radiotherapy plan to be developed before arrival in Shanghai.
How CMCS Supports Your Journey
CMCS is not a hospital — we are your dedicated medical concierge, providing a trusted bridge between international patients and Shanghai's finest cancer specialists.
Our services include:
- ✅ Direct appointment coordination with Dr. Li Fangjuan and the Shanghai Pulmonary Hospital radiation oncology team
- ✅ CT, PET-CT, and pathology translation and pre-consultation review
- ✅ Second opinion facilitation
- ✅ Treatment scheduling and hospital coordination support
- ✅ Accommodation and logistics coordination in Shanghai
- ✅ Post-treatment follow-up and remote check-in support
Contact CMCS
If you or a loved one has been diagnosed with lung cancer and would like to explore SBRT or IMRT radiation therapy options in Shanghai, our team is ready to help.
📧 Email: contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 Website: www.medicalsh.com
CMCS — China Medical Concierge Shanghai. Connecting international patients with Shanghai's finest specialists.
댓글 0개